6676 Stock Overview

Engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. More details

6676 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings have grown 19.3% per year over the past 5 years

Risk Analysis

Has less than 1 year of cash runway

Does not have a meaningful market cap (NT$3B)

My Notes

Capture your thoughts, links and company narrative

Sunny Pharmtech Inc. Competitors

Johnson Chemical Pharmaceutical Works

TPEX:4747

NT$3.1b

Syngen BiotechLtd

TPEX:8279

NT$3.4b

SunWay Biotech

TPEX:1271

NT$5.2b

Genovate Biotechnology

TPEX:4130

NT$2.6b

Price History & Performance

Summary of share price highs, lows and changes for Sunny Pharmtech
Historical stock prices
Current Share Price	NT$20.65
52 Week High	NT$33.80
52 Week Low	NT$19.85
Beta	0.030
1 Month Change	-8.02%
3 Month Change	-14.85%
1 Year Change	-34.86%
3 Year Change	-10.22%
5 Year Change	n/a
Change since IPO	-12.31%

Recent updates

Shareholder Returns

	6676	TW Pharmaceuticals	TW Market
7D	-2.4%	6.1%	-0.7%
1Y	-34.9%	5.0%	26.3%

Return vs Industry: 6676 underperformed the TW Pharmaceuticals industry which returned 5% over the past year.

Return vs Market: 6676 underperformed the TW Market which returned 26.3% over the past year.

Price Volatility

Is 6676's price volatile compared to industry and market?
6676 volatility
6676 Average Weekly Movement	3.9%
Pharmaceuticals Industry Average Movement	3.9%
Market Average Movement	4.5%
10% most volatile stocks in TW Market	8.0%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 6676 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 6676's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1994	144	Yon-Lian Wu	www.sunnypharmtech.com

Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage. The company was founded in 1994 and is based in Taoyuan, Taiwan.

Sunny Pharmtech Inc. Fundamentals Summary

How do Sunny Pharmtech's earnings and revenue compare to its market cap?
6676 fundamental statistics
Market cap	NT$3.08b
Earnings (TTM)	-NT$50.48m
Revenue (TTM)	NT$485.01m

6.3x

P/S Ratio

-60.9x

P/E Ratio

Is 6676 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6676 income statement (TTM)
Revenue	NT$485.01m
Cost of Revenue	NT$203.81m
Gross Profit	NT$281.20m
Other Expenses	NT$331.68m
Earnings	-NT$50.48m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.34
Gross Margin	57.98%
Net Profit Margin	-10.41%
Debt/Equity Ratio	29.7%

How did 6676 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 16:12
End of Day Share Price	2025/02/07 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sunny Pharmtech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.